Lisa E. Baker - Publications

Affiliations: 
Western Michigan University, Kalamazoo, MI, United States 
Area:
Neuropharmacology, drugs of abuse

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Johnson CB, Walther D, Baggott MJ, Baker LE, Baumann MH. Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine. The Journal of Pharmacology and Experimental Therapeutics. PMID 38272669 DOI: 10.1124/jpet.123.001837  0.301
2021 Thomas AM, Cargile KJ, Lunn JA, Baker LE. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats. Behavioural Pharmacology. 32: 524-532. PMID 34397448 DOI: 10.1097/FBP.0000000000000647  0.56
2020 Herr KA, Baker LE. Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats. Behavioural Pharmacology. PMID 32960851 DOI: 10.1097/FBP.0000000000000589  0.44
2020 Risca HI, Zuarth-Gonzalez JD, Baker LE. Conditioned place preference following concurrent treatment with 3, 4-Methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 173032. PMID 32888971 DOI: 10.1016/J.Pbb.2020.173032  0.743
2020 Kohler RJ, Cibelli J, Baker LE. Combined effects of mephedrone and cocaine on locomotor activity and conditioned place preference in male Sprague-Dawley rats. Behavioural Pharmacology. PMID 32032101 DOI: 10.1097/Fbp.0000000000000539  0.6
2019 Bullock TA, Berquist MD, Baker LE. Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine. Behavioural Pharmacology. PMID 31268871 DOI: 10.1097/Fbp.0000000000000491  0.553
2018 Risca HI, Baker LE. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats. Psychopharmacology. PMID 30554256 DOI: 10.1007/S00213-018-5145-8  0.748
2017 Kohler RJ, Perrine SA, Baker LE. Concurrent repeated exposure to 3,4-Methylenedioxypyrovalerone and cocaine produce locomotor sensitization with minimal effects on brain monoamines. Neuropharmacology. PMID 29042316 DOI: 10.1016/J.Neuropharm.2017.10.019  0.535
2017 Berquist MD, Thompson NA, Baker LE. Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone. Psychopharmacology. PMID 28815279 DOI: 10.1007/S00213-017-4716-4  0.452
2017 Harvey EL, Burroughs RL, Baker LE. Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate D-amphetamine. Behavioural Pharmacology. PMID 28704276 DOI: 10.1097/Fbp.0000000000000328  0.79
2017 Berquist MD, Baker LE. Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats. Behavioural Pharmacology. PMID 28598863 DOI: 10.1097/Fbp.0000000000000310  0.64
2017 Baker LE. Hallucinogens in Drug Discrimination. Current Topics in Behavioral Neurosciences. PMID 28484970 DOI: 10.1007/7854_2017_476  0.434
2016 Berquist MD, Traxler HK, Mahler AM, Baker LE. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Drug and Alcohol Dependence. PMID 27181413 DOI: 10.1016/J.Drugalcdep.2016.05.001  0.456
2015 Harvey EL, Baker LE. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture. Psychopharmacology. PMID 26558618 DOI: 10.1007/S00213-015-4142-4  0.793
2015 Walters JL, Lansdell TA, Lookingland KJ, Baker LE. The effects of gestational and chronic atrazine exposure on motor behaviors and striatal dopamine in male Sprague-Dawley rats. Toxicology and Applied Pharmacology. PMID 26440580 DOI: 10.1016/J.Taap.2015.09.026  0.369
2015 Quisenberry AJ, Baker LE. Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats. Psychopharmacology. PMID 26374456 DOI: 10.1007/S00213-015-4065-0  0.775
2015 Berquist MD, Peet MM, Baker LE. Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice. Behavioural Pharmacology. 26: 180-3. PMID 25485643 DOI: 10.1097/Fbp.0000000000000121  0.473
2013 Quisenberry AJ, Prisinzano T, Baker LE. Combined effects of modafinil and d-amphetamine in male Sprague-Dawley rats trained to discriminate d-amphetamine. Pharmacology, Biochemistry, and Behavior. 110: 208-15. PMID 23880213 DOI: 10.1016/J.Pbb.2013.07.011  0.776
2013 Quisenberry AJ, Prisinzano TE, Baker LE. Modafinil alone and in combination with low dose amphetamine does not establish conditioned place preference in male Sprague-Dawley rats. Experimental and Clinical Psychopharmacology. 21: 252-8. PMID 23647093 DOI: 10.1037/A0031832  0.765
2012 Lotfizadeh AD, Redner R, Edwards TL, Quisenberry AJ, Baker LE, Poling A. Effects of altering motivation for food in rats trained with food reinforcement to discriminate between d-amphetamine and saline injections. Pharmacology, Biochemistry, and Behavior. 103: 168-73. PMID 22963928 DOI: 10.1016/J.Pbb.2012.08.026  0.761
2012 Panos JJ, Baker LE. Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats. Pharmacology, Biochemistry, and Behavior. 100: 377-81. PMID 21978942 DOI: 10.1016/J.Pbb.2011.09.007  0.776
2011 Peet MM, Baker LE. Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A. Behavioural Pharmacology. 22: 450-7. PMID 21814135 DOI: 10.1097/Fbp.0B013E328349Fc1B  0.489
2010 Killinger BA, Peet MM, Baker LE. Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 96: 260-5. PMID 20493209 DOI: 10.1016/J.Pbb.2010.05.014  0.469
2010 Panos JJ, Baker LE. An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague-Dawley rats. Psychopharmacology. 209: 95-102. PMID 20112010 DOI: 10.1007/S00213-009-1774-2  0.754
2009 Baker LE, Panos JJ, Killinger BA, Peet MM, Bell LM, Haliw LA, Walker SL. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. Psychopharmacology. 203: 203-11. PMID 19153716 DOI: 10.1007/S00213-008-1458-3  0.751
2008 Poling A, Morgan-Paisley K, Panos JJ, Kim EM, O'Hare E, Cleary JP, Lesné S, Ashe KH, Porritt M, Baker LE. Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures. Behavioural Brain Research. 193: 230-4. PMID 18585407 DOI: 10.1016/J.Bbr.2008.06.001  0.629
2008 Baker LE, Searcy GD, Pynnonen DM, Poling A. Differentiating the discriminative stimulus effects of gamma-hydroxybutyrate and ethanol in a three-choice drug discrimination procedure in rats. Pharmacology, Biochemistry, and Behavior. 89: 598-607. PMID 18374971 DOI: 10.1016/J.Pbb.2008.02.016  0.483
2008 Kueh D, Iwamoto K, Poling A, Baker LE. Effects of gamma-hydroxybutyrate (GHB) and its metabolic precursors on delayed-matching-to-position performance in rats. Pharmacology, Biochemistry, and Behavior. 89: 179-87. PMID 18201754 DOI: 10.1016/J.Pbb.2007.12.007  0.779
2008 Laraway S, Snycerski S, Baker LE, Poling A. Gamma-hydroxybutyrate (GHB) reduces operant behavior without impairing working memory in rats responding under fixed-consecutive-number schedules. Pharmacology, Biochemistry, and Behavior. 88: 205-12. PMID 17904624 DOI: 10.1016/J.Pbb.2007.08.002  0.406
2007 Kueh D, Baker LE. Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine. Psychopharmacology. 189: 447-57. PMID 17019568 DOI: 10.1007/S00213-006-0523-Z  0.818
2005 Baker LE, Van Tilburg TJ, Brandt AE, Poling A. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats. Psychopharmacology. 181: 458-66. PMID 16001124 DOI: 10.1007/S00213-005-0003-X  0.554
2004 Baker LE, Pynnonen D, Poling A. Influence of reinforcer type and route of administration on gamma-hydroxybutyrate discrimination in rats. Psychopharmacology. 174: 220-7. PMID 14991222 DOI: 10.1007/S00213-003-1744-Z  0.49
2004 Prus AJ, Baker LE, Meltzer HY. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms. Pharmacology, Biochemistry, and Behavior. 77: 199-208. PMID 14751446 DOI: 10.1016/J.Pbb.2003.10.010  0.607
2003 Goodwin AK, Pynnonen DM, Baker LE. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination. Pharmacology, Biochemistry, and Behavior. 74: 987-95. PMID 12667914 DOI: 10.1016/S0091-3057(03)00029-7  0.792
2002 Goodwin AK, Baker LE. An analysis of the utility of differential outcome procedures in drug discrimination research. Behavioural Pharmacology. 13: 271-8. PMID 12218507 DOI: 10.1097/00008877-200207000-00003  0.735
2002 Baker LE, Prus AJ. Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonist. Pharmacology, Biochemistry, and Behavior. 73: 753-8. PMID 12213519 DOI: 10.1016/S0091-3057(02)00882-1  0.422
2001 Goudie AJ, Baker LE, Smith JA, Prus AJ, Svensson KA, Cortes-Burgos LA, Wong EH, Haadsma-Svensson S. Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D3 preferring antagonist PNU-99194a: an analysis of possible mechanisms. Behavioural Pharmacology. 12: 303-15. PMID 11710745 DOI: 10.1097/00008877-200109000-00001  0.395
2001 Christian AJ, Goodwin AK, Baker LE. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A. Pharmacology, Biochemistry, and Behavior. 68: 371-7. PMID 11325388 DOI: 10.1016/S0091-3057(00)00470-6  0.769
2000 Goodwin AK, Baker LE. A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats. Experimental and Clinical Psychopharmacology. 8: 415-23. PMID 10975633 DOI: 10.1037//1064-1297.8.3.415  0.787
2000 Byrne T, Baker LE, Poling A. MDMA and learning: effects of acute and neurotoxic exposure in the rat. Pharmacology, Biochemistry, and Behavior. 66: 501-8. PMID 10899362 DOI: 10.1016/S0091-3057(00)00227-6  0.484
1999 Virden TB, Baker LE. Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine. Behavioural Pharmacology. 10: 195-204. PMID 10780832 DOI: 10.1097/00008877-199903000-00008  0.54
1999 Baker LE, Hood CA, Heidema AM. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats. Behavioural Pharmacology. 10: 717-22. PMID 10780286 DOI: 10.1097/00008877-199912000-00002  0.481
1999 Garner KJ, Baker LE. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline. Pharmacology, Biochemistry, and Behavior. 64: 373-8. PMID 10515316 DOI: 10.1016/S0091-3057(99)00064-7  0.574
1998 Baker LE, Svensson KA, Garner KJ, Goodwin AK. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. European Journal of Pharmacology. 358: 101-9. PMID 9808258 DOI: 10.1016/S0014-2999(98)00582-2  0.786
1998 Franklin SR, Baker LE, Svensson KA. Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A. Psychopharmacology. 138: 40-6. PMID 9694525 DOI: 10.1007/S002130050643  0.526
1998 Baker LE. (+)-7-OH-DPAT PRODUCES STIMULUS GENERALIZATION IN RATS TRAINED TO DISCRIMINATE d-AMPHETAMINE Behavioural Pharmacology. 9: S104. DOI: 10.1097/00008877-199808000-00240  0.389
1997 Baker LE, Miller ME, Svensson KA. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants. Behavioural Pharmacology. 8: 243-52. PMID 9833019  0.523
1997 Morgan TB, Baker LE. The application of differential outcomes to a cocaine--saline discrimination procedure. Behavioural Pharmacology. 8: 31-6. PMID 9832998 DOI: 10.1097/00008877-199702000-00003  0.487
1997 Baker LE, Virden TB, Miller ME, Sullivan CL. Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA). Pharmacology, Biochemistry, and Behavior. 58: 505-16. PMID 9300612 DOI: 10.1016/S0091-3057(97)00287-6  0.506
1997 Baker LE, Taylor MM. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Pharmacology, Biochemistry, and Behavior. 57: 737-48. PMID 9259001 DOI: 10.1016/S0091-3057(96)00334-6  0.554
1996 Baker LE, Makhay MM. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats. Pharmacology, Biochemistry, and Behavior. 53: 455-61. PMID 8808158 DOI: 10.1016/0091-3057(95)02017-9  0.55
1995 Baker LE, Broadbent J, Michael EK, Matthews PK, Metosh CA, Saunders RB, West WB, Appel JB. Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA). Behavioural Pharmacology. 6: 263-275. PMID 11224335 DOI: 10.1097/00008877-199504000-00007  0.767
1993 Baker LE, Riddle EE, Saunders RB, Appel JB. The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behavioural Pharmacology. 4: 69-79. PMID 11224173 DOI: 10.1097/00008877-199302000-00008  0.654
1991 Appel JB, Baker LE, Barrett RL, Broadbent J, Michael EM, Riddle EE, Van Groll BJ. Use of drug discrimination in drug abuse research. Nida Research Monograph. 369-97. PMID 1369679 DOI: 10.1037/E496182006-023  0.581
Show low-probability matches.